Literature DB >> 23739629

Monitoring states of altered carbohydrate metabolism via breath analysis: are times ripe for transition from potential to reality?

Newsha Dowlaty1, Amanda Yoon, Pietro Galassetti.   

Abstract

PURPOSE OF REVIEW: To introduce the potential of breath analysis as a diagnostic or monitoring tool in diabetes. RECENT
FINDINGS: Blood testing for plasma glucose and other metabolic variables is the base for the diagnosis and management of diabetes, whose two main types (type 1 and type 2, T1DM, T2DM) are projected to affect 450 million by 2030. As blood testing is often uncomfortable, painful, costly, and in some situations unreliable, the quest for alternative, noninvasive methods has been ongoing for decades. Breath analysis has emerged as an ideal alternative as sample collection is easy, painless, flexible, noninvasive, practical, and inexpensive. No single exhaled gas can reflect systemic glucose concentrations. Multiple gases, however, have been linked to various aspects of glucose metabolism, and integrated analysis of their simultaneous profiles during prolonged glycemic fluctuations has yielded accurate predictions of plasma values, building expectation that a clinically usable breath-based glucometer may be developed within a few years.
SUMMARY: While prototypes of hand-held breath testing glucometers may still be several years away, current research shows the imminent promise of this methodology and the widening support for its development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739629      PMCID: PMC4060961          DOI: 10.1097/MCO.0b013e328361f91f

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  47 in total

1.  Exhaled breath condensate: methodological recommendations and unresolved questions.

Authors:  I Horváth; J Hunt; P J Barnes; K Alving; A Antczak; E Baraldi; G Becher; W J C van Beurden; M Corradi; R Dekhuijzen; R A Dweik; T Dwyer; R Effros; S Erzurum; B Gaston; C Gessner; A Greening; L P Ho; J Hohlfeld; Q Jöbsis; D Laskowski; S Loukides; D Marlin; P Montuschi; A C Olin; A E Redington; P Reinhold; E L J van Rensen; I Rubinstein; P Silkoff; K Toren; G Vass; C Vogelberg; H Wirtz
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

2.  Exhaled volatile organic compounds identify patients with colorectal cancer.

Authors:  D F Altomare; M Di Lena; F Porcelli; L Trizio; E Travaglio; M Tutino; S Dragonieri; V Memeo; G de Gennaro
Journal:  Br J Surg       Date:  2013-01       Impact factor: 6.939

3.  Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes.

Authors:  Jaime S Rosa; Stacy R Oliver; Rebecca L Flores; Jerry Ngo; Ginger L Milne; Frank P Zaldivar; Pietro R Galassetti
Journal:  Pediatr Diabetes       Date:  2011-03-28       Impact factor: 4.866

Review 4.  Regulation of gene expression by carbon dioxide.

Authors:  Cormac T Taylor; Eoin P Cummins
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

5.  Identification of characteristic molecular signature for volatile organic compounds in peripheral blood of rat.

Authors:  Jeong Kyu Kim; Kwang Hwa Jung; Ji Heon Noh; Jung Woo Eun; Hyun Jin Bae; Hong Jian Xie; Ja-June Jang; Jae Chun Ryu; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-16       Impact factor: 4.219

6.  Blood and breath levels of selected volatile organic compounds in healthy volunteers.

Authors:  Paweł Mochalski; Julian King; Martin Klieber; Karl Unterkofler; Hartmann Hinterhuber; Matthias Baumann; Anton Amann
Journal:  Analyst       Date:  2013-02-25       Impact factor: 4.616

7.  Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.

Authors:  Mandy Mangler; Cornelia Freitag; Malgorzata Lanowska; Oliver Staeck; Achim Schneider; Dorothee Speiser
Journal:  Ginekol Pol       Date:  2012-10       Impact factor: 1.232

8.  Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.

Authors:  Beth Enderby; David Smith; W Carroll; W Lenney
Journal:  Pediatr Pulmonol       Date:  2009-02

9.  Methyl iodide-induced fetal hypothyroidism implicated in late-stage fetal death in rabbits.

Authors:  E Sloter; M Nemec; D Stump; J Holson; D Kirkpatrick; M Gargas; J Kinzell
Journal:  Inhal Toxicol       Date:  2009-05       Impact factor: 2.724

10.  Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes.

Authors:  B J Novak; D R Blake; S Meinardi; F S Rowland; A Pontello; D M Cooper; P R Galassetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

View more
  5 in total

1.  Antioxidant Effect of Tyr-Ala Extracted from Zein on INS-1 Cells and Type 2 Diabetes High-Fat-Diet-Induced Mice.

Authors:  Jinghui Zhai; Yuhua Zhu; Yi Wu; Na Li; Yue Cao; Yi Guo; Li Xu
Journal:  Antioxidants (Basel)       Date:  2022-06-02

Review 2.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

3.  Investigation of Exhaled Breath Samples from Patients with Alzheimer's Disease Using Gas Chromatography-Mass Spectrometry and an Exhaled Breath Sensor System.

Authors:  Hui-Chong Lau; Joon-Boo Yu; Ho-Won Lee; Jeung-Soo Huh; Jeong-Ok Lim
Journal:  Sensors (Basel)       Date:  2017-08-03       Impact factor: 3.576

4.  Comprehensive Two-Dimensional Gas Chromatography-Mass Spectrometry Analysis of Exhaled Breath Compounds after Whole Grain Diets.

Authors:  Kaisa Raninen; Ringa Nenonen; Elina Järvelä-Reijonen; Kaisa Poutanen; Hannu Mykkänen; Olavi Raatikainen
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

5.  Salivary molecular spectroscopy: A sustainable, rapid and non-invasive monitoring tool for diabetes mellitus during insulin treatment.

Authors:  Douglas C Caixeta; Emília M G Aguiar; Léia Cardoso-Sousa; Líris M D Coelho; Stephanie W Oliveira; Foued S Espindola; Leandro Raniero; Karla T B Crosara; Matthew J Baker; Walter L Siqueira; Robinson Sabino-Silva
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.